EA202192132A1 - Улучшенный нитратный состав и способы применения - Google Patents
Улучшенный нитратный состав и способы примененияInfo
- Publication number
- EA202192132A1 EA202192132A1 EA202192132A EA202192132A EA202192132A1 EA 202192132 A1 EA202192132 A1 EA 202192132A1 EA 202192132 A EA202192132 A EA 202192132A EA 202192132 A EA202192132 A EA 202192132A EA 202192132 A1 EA202192132 A1 EA 202192132A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- application
- nitrate composition
- subject
- source
- Prior art date
Links
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 229910002651 NO3 Inorganic materials 0.000 title 1
- 239000002184 metal Substances 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 230000037147 athletic performance Effects 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Catalysts (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962800361P | 2019-02-01 | 2019-02-01 | |
| US201962866540P | 2019-06-25 | 2019-06-25 | |
| PCT/US2020/016274 WO2020160509A1 (en) | 2019-02-01 | 2020-01-31 | Enhanced nitrate compositions and methods of use |
| US16/779,349 US20200222449A1 (en) | 2019-02-01 | 2020-01-31 | Enhanced Nitrate Compositions and Methods of Use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202192132A1 true EA202192132A1 (ru) | 2021-10-19 |
Family
ID=71517286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202192132A EA202192132A1 (ru) | 2019-02-01 | 2020-01-31 | Улучшенный нитратный состав и способы применения |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US20200222449A1 (https=) |
| EP (1) | EP3917543A4 (https=) |
| JP (1) | JP7534310B2 (https=) |
| KR (1) | KR102789451B1 (https=) |
| CN (1) | CN113498345A (https=) |
| AU (2) | AU2020215729B2 (https=) |
| BR (1) | BR112021015110A2 (https=) |
| CA (1) | CA3128232A1 (https=) |
| EA (1) | EA202192132A1 (https=) |
| IL (1) | IL285247A (https=) |
| MX (1) | MX2021009287A (https=) |
| WO (1) | WO2020160509A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8466187B2 (en) | 2007-09-18 | 2013-06-18 | Thermolife International, Llc | Amino acid compositions |
| US12612370B2 (en) | 2011-03-02 | 2026-04-28 | Thermolife International, Llc | Amino acid compositions |
| WO2022192743A1 (en) * | 2021-03-11 | 2022-09-15 | Thermolife International, Llc | Enhanced nitrate, elemental metal, and amino acid compositions and methods of use |
| US11865139B2 (en) | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
| WO2022174116A1 (en) * | 2021-02-11 | 2022-08-18 | Thermolife International, Llc | A method of administering nitric oxide gas |
| JP2024541338A (ja) * | 2020-11-12 | 2024-11-08 | サーモライフ インターナショナル， エルエルシー | 血中酸素飽和度を増大させる方法 |
| AU2022220004A1 (en) * | 2021-02-11 | 2023-08-17 | Thermolife International, Llc | A method of administering nitric oxide gas |
| JP2024508952A (ja) * | 2021-03-11 | 2024-02-28 | サーモライフ インターナショナル， エルエルシー | ニトレートと単体金属とアミノ酸との増強された組成物ならびに使用方法 |
| CA3226249A1 (en) * | 2021-08-16 | 2023-02-23 | Thermolife International, Llc | Iron supplement compositions and methods of use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU476799B2 (en) * | 1974-02-04 | 1976-08-05 | Carlton And United Breweries Limited | Preparation of a water soluble isomerised hop extract |
| US6703056B2 (en) * | 2000-09-29 | 2004-03-09 | The Procter + Gamble Co. | Beverage compositions comprising arabinogalactan and defined minerals |
| US7208170B2 (en) * | 2002-09-20 | 2007-04-24 | Petersson Lennart G | Powder teat dip germicide, fungicide and skin conditioner |
| CN100399948C (zh) * | 2002-12-06 | 2008-07-09 | 协和发酵工业株式会社 | 含氨基酸的饮料和减少氨基酸苦味的方法 |
| DK2124638T3 (en) | 2007-02-26 | 2017-03-20 | Heartbeet Ltd | COMPOSITION INCREASING PERFORMANCE AND USING IT |
| US10646508B1 (en) * | 2007-09-18 | 2020-05-12 | Thermolife International, Llc | Method of safely administering nitrate dietary supplements and compositions |
| US7777074B2 (en) | 2007-09-18 | 2010-08-17 | Thermolife International, Llc | Amino acid compounds |
| US20110123654A1 (en) * | 2008-06-06 | 2011-05-26 | Ralf Jaeger | Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| US8303995B1 (en) * | 2008-06-13 | 2012-11-06 | Board Of Regents, The University Of Texas System | Nitrite formulations and their use as nitric oxide prodrugs |
| ES2538652T3 (es) | 2009-06-16 | 2015-06-23 | Dusan Miljkovic | Composiciones y procedimientos para producir un potencial negativo de oxidación-reducción estable en materiales consumibles |
| JP2014513527A (ja) | 2011-04-21 | 2014-06-05 | ネステク ソシエテ アノニム | パフォーマンス向上のための栄養組成物並びにその作製及び使用方法 |
| JP6016610B2 (ja) | 2012-12-20 | 2016-10-26 | 江崎グリコ株式会社 | 筋肉増量用サプリメント |
| CA2965441C (en) * | 2014-10-22 | 2020-03-24 | Innoveco Australia Pty. Ltd. | Process for metal extraction with sorption leaching in wet solids |
| ES2651717B1 (es) | 2016-07-26 | 2018-11-16 | Lara OLLER DUQUE | Solución acuosa cristaloide isotónica |
| US10624921B2 (en) * | 2016-11-15 | 2020-04-21 | Berkeley Nox Limited | Dietary supplements |
| WO2020214841A1 (en) * | 2019-04-16 | 2020-10-22 | Thermolife International, Llc | Hexylamine salts and methods of using hexylamine |
-
2020
- 2020-01-31 MX MX2021009287A patent/MX2021009287A/es unknown
- 2020-01-31 EP EP20749283.6A patent/EP3917543A4/en active Pending
- 2020-01-31 AU AU2020215729A patent/AU2020215729B2/en active Active
- 2020-01-31 KR KR1020217027218A patent/KR102789451B1/ko active Active
- 2020-01-31 CA CA3128232A patent/CA3128232A1/en active Pending
- 2020-01-31 EA EA202192132A patent/EA202192132A1/ru unknown
- 2020-01-31 US US16/779,349 patent/US20200222449A1/en active Pending
- 2020-01-31 JP JP2021544571A patent/JP7534310B2/ja active Active
- 2020-01-31 WO PCT/US2020/016274 patent/WO2020160509A1/en not_active Ceased
- 2020-01-31 CN CN202080018208.XA patent/CN113498345A/zh active Pending
- 2020-01-31 BR BR112021015110A patent/BR112021015110A2/pt unknown
-
2021
- 2021-07-29 IL IL285247A patent/IL285247A/en unknown
-
2023
- 2023-06-12 AU AU2023203649A patent/AU2023203649B2/en active Active
- 2023-12-28 US US18/399,677 patent/US20240122969A1/en active Pending
- 2023-12-28 US US18/399,664 patent/US20240122967A1/en active Pending
- 2023-12-28 US US18/399,465 patent/US20240122966A1/en active Pending
- 2023-12-28 US US18/399,668 patent/US20240122968A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020215729B2 (en) | 2023-03-30 |
| JP2022523513A (ja) | 2022-04-25 |
| EP3917543A4 (en) | 2022-10-12 |
| KR102789451B1 (ko) | 2025-03-31 |
| KR20210119499A (ko) | 2021-10-05 |
| US20200222449A1 (en) | 2020-07-16 |
| US20240122967A1 (en) | 2024-04-18 |
| AU2020215729A1 (en) | 2021-09-02 |
| AU2023203649B2 (en) | 2024-11-14 |
| CA3128232A1 (en) | 2020-08-06 |
| WO2020160509A1 (en) | 2020-08-06 |
| EP3917543A1 (en) | 2021-12-08 |
| US20240122968A1 (en) | 2024-04-18 |
| US20240122966A1 (en) | 2024-04-18 |
| US20240122969A1 (en) | 2024-04-18 |
| MX2021009287A (es) | 2021-11-12 |
| CN113498345A (zh) | 2021-10-12 |
| AU2023203649A1 (en) | 2023-07-06 |
| JP7534310B2 (ja) | 2024-08-14 |
| BR112021015110A2 (pt) | 2022-01-11 |
| IL285247A (en) | 2021-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202192132A1 (ru) | Улучшенный нитратный состав и способы применения | |
| MY209267A (en) | Compositions and methods of use of -hydroxy--methylbutyrate (hmb) assosiated with intermittent fasting | |
| PH12021550882A1 (en) | Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders | |
| WO2018210793A3 (en) | ANTI-SIRPα ANTIBODIES | |
| MX2022012091A (es) | Moleculas de union al antigeno multiespecificas dirigidas a ligando de tipo delta 3 (dll3) y sus usos. | |
| FR2894585B1 (fr) | Copolymere comprenant des unites zwitterioniques et d'autres unites, composition comprenant le copolymere, et utilisation | |
| PH12012501687A1 (en) | Acetylcysteine composition and uses therefor | |
| EA200501000A3 (ru) | Связывающие агенты, ингибирующие миостатин | |
| PH12020552092A1 (en) | Tetrahydro-1h-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease | |
| PH12021500034A1 (en) | Compounds useful in hiv therapy | |
| MX2021004073A (es) | Lamina de acero de alta resistencia y metodo para la fabricacion de la misma. | |
| PH12020500664A1 (en) | C3-binding agents and methods of use thereof | |
| MX2023015489A (es) | Metodos y composiciones para tratar un trastorno asociado al angiotensinogeno (agt). | |
| ZA202309567B (en) | Binding molecule against dll3 and use thereof | |
| WO2022147463A3 (en) | Binder molecules with high affinity and/ or specificity and methods of making and use thereof | |
| ATE477350T1 (de) | Eglin stahl- eine niedriglegierte hochfeste zusammensetzung | |
| EA202192925A1 (ru) | Твердые формы ингибитора glyt1 | |
| EA202092064A1 (ru) | Способы изменения состава тела | |
| MX2025006853A (es) | Degradadores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos | |
| EA201992352A1 (ru) | Фунгицидные комбинации | |
| WO2023159234A3 (en) | Methods and compositions for treating or ameliorating cardiac muscle arrhythmias and skeletal muscle tremors | |
| ZA202207601B (en) | Treatment of acute heart failure | |
| PH12021552307A1 (en) | Athletic ability enhancing composition | |
| FR3109312A1 (fr) | Compositions capillaires comprenant un polysaccharide modifié et des ions multivalents | |
| WO2023183247A3 (en) | Methods and compositions for suppression of biogenic amines produced by the gut microbiome |